Lombardi: Stock Market Commentary & Forecasts, Financial & Economic Analysis Since 1986

One in Five Companies Warning on Earnings?

By for Profit Confidential

All of a Sudden, Quarterly Corporate Earnings Are in TroubleTraditionally, the first big American public company to kick off each new corporate earnings season is Alcoa Inc. (NYSE/AA). For the current quarter, Alcoa reported a net loss of $178 million, or $0.16 per diluted share. The company stated it had some special restructuring costs in the quarter; if you were to exclude them, its corporate earnings were $0.09 per share. (Source: Alcoa Inc., April 8, 2014.)

As usual, investors grasping for any good news as a reason to push stock prices higher didn’t hold back. The chart below shows what happened as soon as the market for Alcoa shares opened after its corporate earnings release.

Alcoa Inc ChartChart courtesy of www.StockCharts.com

Alcoa’s stock prices gapped up almost five percent on its news that “it lost money but really didn’t lose money if restructuring charges were excluded.”

But how did Alcoa really do? The first thing I would do as an investor is see if sales at Alcoa are rising. In this case, Alcoa reported its revenue fell 6.5% in the quarter from the same quarter last year.

Then I would look at stock buybacks. Did Alcoa buy back any of its stock in the quarter that would have the effect of boosting its quarterly per-share earnings? Well, lo and behold, in the first quarter, the number of Alcoa’s diluted shares declined by more than five percent!

Please don’t get me wrong. I’m not saying Alcoa shares are a sell. In fact, I don’t follow the company at all. But when I see the stock market pushing the stock price of a company higher despite the company reporting a corporate earnings loss, declining earnings, and a stock buyback, I just get more concerned about stock valuations.

Dear reader, the party goes on until the punchbowl is taken away. We are seeing the signs of the party that began on key stock indices in 2009 ending soon. As of March 31, 18.6% of the S&P 500 companies have issued negative corporate earnings guidance for the first qua… Read More

My Top Company for Income and Capital Gains

By for Profit Confidential

Why Every Investor Should Consider a Stock Like This One at This TimeOnce again, Johnson & Johnson (JNJ) has come through for investors. The company just reported a very solid first-quarter earnings report.

Continued strength in the company’s pharmaceutical business is the big reason for the growth. Total global sales grew 3.5% to $18.1 billion, with domestic sales growing 2.2% and international sales growing 4.5%.

Notable in the company’s latest numbers was strength in European sales, which is an emerging trend this earnings season. Johnson & Johnson reported a nine-percent gain in sales to Europe, growing to $4.89 billion during the quarter.

Excluding some one-time items, first-quarter earnings were $4.4 billion, or $1.54 per diluted share, for an increase of 7.8% and 6.9%, respectively, over the same quarter of 2013.

The company boosted its full-year 2014 earnings guidance to between $5.80 and $5.90 per share, up from the previous $5.75 to $5.85 per-share range excluding special items.

After the stock market sell-off in January, Johnson & Johnson’s share price dropped to around $87.00 a share by early February. It has since made a full recovery, now trading close to $100.00.

I still view this company as a position worth considering for a long-term portfolio when it’s down. Typically, the stock isn’t down for long. Its five-year stock chart is featured below:

Johnson & Johnson ChartChart courtesy of www.StockCharts.com

According to its numbers, Johnson & Johnson’s consumer products business is pretty flat, while medical device growth can be volatile. The anchor to the company’s business and its profitability remains pharmaceuticals, but the other business lines are complementary. Instead of just a pure-play large-cap pharma business, the diversification among other product lines helps with cash flow.

Johnson & Johnson has a track record of announcing dividend increases in the second quarter, particularly tow… Read More

My Simple, Safe Investment Strategy for Playing Risky Stocks

By for Profit Confidential

Here's a Strategy to Play Momentum Stocks While Limiting RiskThere’s some hand-holding required out there in the stock market. We have seen destruction in the momentum biotech and Internet stocks that have corrected by more than 30%.

Now we are hearing some analysts on Wall Street saying to jump back in—but I’m hesitant at this juncture, as the downward risk is likely not over yet.

The reality is that, given the superlative gains recorded in 2013 by many of these biotech and technology momentum stocks, you shouldn’t be surprised to see the current malaise.

The fact that many of these highflying stocks in the stock market have more than doubled in a year should be a red flag. My simplest advice is to wait for the selling to subside in the stock market before you jump into these stocks.

You also need to be careful when hearing the bullish comments by Wall Street firms on these momentum stocks. Many of these firms have investment banking relationships with these stocks; it’s only natural to support your clients in the bad times.

Don’t get fooled by the stock market rhetoric. Instead, take a prudent approach to the stock market.

You don’t want to be caught exposed on this stock market unless you are fine with losing money should the selling intensify. Like I wrote at the beginning of the year, making money on the stock market will not be easy this year and capital preservation should be your objective.

Now, if you are willing to risk some capital and feel a stock market bottom is near, then what I suggest you do is consider using call options as a risk management investment strategy.

By employing call options, you can partake in a possible stock market bounce, while also controlling the amount of capital you have at risk, which is the premium paid for the option.

Let me show you how this simple strategy works using Tesla Motors, Inc. (NASDAQ/TSLA) as an example. (Note: this is only for illustration and is not meant to be an actual trade recommendation.)… Read More

The Great Crash of 2014

A stock market crash bigger than what happened in 2008 and early 2009 is headed our way.

In fact, we are predicting this crash will be even more devastating than the 1929 crash…

…the ramifications of which will hit the economy and Americans deeper than anything we’ve ever seen.

Our 27-year-old research firm feels so strongly about this, we’ve just produced a video to warn investors called, “The Great Crash of 2014”

In case you are not familiar with our research work on the stock market:

In late 2001, in the aftermath of 9/11, we told our clients to buy small-cap stocks. They rose about 100% after we made that call.

We were one of the first major advisors to turn bullish on gold.

Throughout 2002, we urged our readers to buy gold stocks; many of which doubled and even tripled in price.

In November of 2007, we started begging our customers to get out of the stock market. Shortly afterwards, it was widely recognized that October 2007 was the top for stocks.

We correctly predicted the crash in the stock market of 2008 and early 2009.

And in March of 2009, we started telling our readers to jump into small caps. The Russell 2000 gained about 175% from when we made that call in 2009 to today.

Many investors will find our next prediction hard to believe until they see all the proof we have to back it up.

Even if you don’t own stocks, what’s about to happen will affect you!

I urge you to be among the first to get our next major prediction.
See it here now in this just-released alarming video.

This is an entirely free service. No credit card required.

We hate spam as much as you do.
Check out our privacy policy.